Search
for
Sort by
Research 241–270 of 1000+
- Drug eruptions in dermatology
- Dermatologic manifestations of endocrine disorders
- Hair Loss and Hirsutism in the Elderly
- Contraceptive use in acne
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Menopause
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Stress Inhibits Hair Growth in Mice by Induction of Premature Catagen Development and Deleterious Perifollicular Inflammatory Events via Neuropeptide Substance P-Dependent Pathways
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Insulin Resistance and Skin Diseases
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Alopecia Areata
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- ANDROGENETIC ALOPECIA
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Androgen receptor: A promising therapeutic target in breast cancer
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
- Immunomodulators in the treatment of cutaneous lymphoma
- Abiraterone and spironolactone in prostate cancer: a combination to avoid